The solution lies in flexibility. Sites need to be able to work in whatever formats make sense for them, whether that’s a ...

Biogenesis today launched from stealth, backed by Jack Altman’s Alt Capital. Biogenesis builds an automated feasibility ...

The initiative reflects the PPD business’ vision to promote sustainability throughout the clinical development ecosystem.

Shuttle Pharmaceuticals (SHPH) Holdings announced it has finalized agreements with all six of the planned site enrollment locations to administer the Phase 2 clinical trial of Ropidoxuridine for the ...

Preserving trial integrity. Clinical trials are susceptible to timing. Delays in investigational product delivery can stall ...

At OCTSC, an expert delved into how to optimise patient enrollment to achieve retention and clinical trial success.

Applied Clinical Trials recently conducted its State of the Industry survey, capturing perspectives on the current clinical ...

In the world of clinical trials, patient recruitment is an ongoing challenge. | In the world of clinical trials, patient ...

2023 has brought major changes in the clinical research technology industry. As research sites face a backlog of clinical trials, they’re becoming more selective with which studies they take on.

A genetically engineered herpes virus may offer a new and effective treatment for advanced melanoma, providing hope for ...

Natera has announced positive results from the Phase III IMvigor011 clinical trial for muscle-invasive bladder cancer (MIBC).